Our study aims to evaluate the efficacy of intracapsular injection of Terlipressin versus Carbetocin injection on hemoglobin level in women undergoing abdominal laparoscopic myomectomy. Moreover, to evaluate their efficacy in decreasing blood loss on operative time and to describe the injection sequelae for the same population. This clinical study will be conducted in compliance with the clinical study protocol and applicable regulatory requirements.
Women aged 16-45 years
Appropriate medical status for laparoscopic surgery (largest myoma ≤15 cm)
Baseline hemoglobin ≥9 g/dl
No contra-indications to the use of glyopressin or carbitocin
Previous myomectomy
History of bleeding disorders
Concurrent anticoagulation therapy
History of Uncontrolled ischaemic heart disease